Multiple Sclerosis Trial, Not Yet Recruiting NCT07472556 Sponsor: Pasquale Arpaia Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07472556
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with multiple sclerosis according to a standard set of diagnostic guidelines known as the 2017 McDonald Criteria.
  • People who are between 18 and 60 years of age.
  • People who have had no MS flare-ups or new brain/spinal cord changes on imaging in the 3 months before enrolling in the trial.
  • People who have only mild muscle stiffness, as measured by a standard clinical scale (Modified Ashworth Scale score of 1 or less).
  • People who have well-preserved memory and thinking abilities, as measured by a standard cognitive test (a score of 24 or higher on the MMSE).
  • People who are able to understand the study and sign a consent form on their own, without assistance.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cognitive test score (MMSE) is below 24.
  • People who have other neurological or psychiatric conditions that could interfere with the study activities or their ability to understand the procedures involved.
  • People with severe vision problems or physical conditions affecting the arms or hands that would prevent them from completing the tasks or wearing the brain-monitoring cap used in the study.
  • People with skin conditions on the scalp, known allergies to electrode materials, recent brain surgery, or other conditions that make wearing a brain-monitoring (EEG) cap unsafe or unsuitable.
  • People who have any other health condition that the treating doctor considers incompatible with safely taking part in the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 081 746 3741

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Pasquale Arpaia
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
30 September 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Modulation of ERD/ERS patterns during Motor Imagery (MI) tasks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov